|
December 8, 2005 Categories: Uncategorized Posted by admin
At the center of the proposed merger of Boston Scientific Corp. and Guidant Corp. lie two highly profitable heart-repair devices that have boosted their makers’ bottom lines, but are also part of a technology boom that has sharply increased the cost of healthcare in the United States.
Full news
|
|
